Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zile

Showing results (771-780 of 1,060) with videos related to

Pageof 106
Sort By:
Circulation. Heart Failure|July 1, 2011
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trialInder S Anand, Thomas S Rector, John G Cleland, et al.
European Journal of Heart Failure|December 12, 2018
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetesRasmus Rørth, Pardeep S Jhund, Søren L Kristensen, et al.
European Journal of Medical Research|December 5, 2025
Direct thrombectomy versus bridging alteplase medicine in anterior circulation stroke following endovascular therapy: a multi-center cohort studyXuehua Zeng, Mingzhu Feng, Mohammad Mofatteh, et al.
European Journal of Heart Failure|April 9, 2013
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)John J V McMurray, Milton Packer, Akshay S Desai, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 19, 2013
Colloidal HPMO nanoparticles: silica-etching chemistry tailoring, topological transformation, and nano-biomedical applicationsYu Chen, Pengfei Xu, Hangrong Chen, et al.
European Journal of Heart Failure|June 11, 2016
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trialOrly Vardeny, Brian Claggett, Milton Packer, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 11, 2020
SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overloadHannah J Riley, Ryan R Kelly, An O Van Laer, et al.
The Journal of Biological Chemistry|September 13, 2006
Regulation of Ncx1 expression. Identification of regulatory elements mediating cardiac-specific expression and up-regulationLin Xu, Ludivine Renaud, Joachim G Müller, et al.
Journal of Cardiac Failure|May 10, 2011
Hemodynamic factors associated with acute decompensated heart failure: part 2--use in automated detectionPhilip B Adamson, Michael R Zile, Yong K Cho, et al.
Journal of Cardiac Failure|March 29, 2011
Hemodynamic factors associated with acute decompensated heart failure: part 1--insights into pathophysiologyMichael R Zile, Philip B Adamson, Yong K Cho, et al.
Pageof 106

Showing results (771-780 of 1,060) with videos related to

Sort By:
Pageof 106
Circulation. Heart Failure|July 1, 2011
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trialInder S Anand, Thomas S Rector, John G Cleland, et al.
European Journal of Heart Failure|December 12, 2018
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetesRasmus Rørth, Pardeep S Jhund, Søren L Kristensen, et al.
European Journal of Medical Research|December 5, 2025
Direct thrombectomy versus bridging alteplase medicine in anterior circulation stroke following endovascular therapy: a multi-center cohort studyXuehua Zeng, Mingzhu Feng, Mohammad Mofatteh, et al.
European Journal of Heart Failure|April 9, 2013
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)John J V McMurray, Milton Packer, Akshay S Desai, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 19, 2013
Colloidal HPMO nanoparticles: silica-etching chemistry tailoring, topological transformation, and nano-biomedical applicationsYu Chen, Pengfei Xu, Hangrong Chen, et al.
European Journal of Heart Failure|June 11, 2016
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trialOrly Vardeny, Brian Claggett, Milton Packer, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 11, 2020
SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overloadHannah J Riley, Ryan R Kelly, An O Van Laer, et al.
The Journal of Biological Chemistry|September 13, 2006
Regulation of Ncx1 expression. Identification of regulatory elements mediating cardiac-specific expression and up-regulationLin Xu, Ludivine Renaud, Joachim G Müller, et al.
Journal of Cardiac Failure|May 10, 2011
Hemodynamic factors associated with acute decompensated heart failure: part 2--use in automated detectionPhilip B Adamson, Michael R Zile, Yong K Cho, et al.
Journal of Cardiac Failure|March 29, 2011
Hemodynamic factors associated with acute decompensated heart failure: part 1--insights into pathophysiologyMichael R Zile, Philip B Adamson, Yong K Cho, et al.
Pageof 106